Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

US Stem Cell Inc (USRM)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.000001 0.000000    0.00%
16/04 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.000000 / 0.000000
  • Day's Range: 0.000001 - 0.000001
US Stem Cell 0.000001 0.000000 0.00%

US Stem Cell Inc Company Profile

 
Get an in-depth profile of US Stem Cell Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

11

Equity Type

ORD

U.S. Stem Cell, Inc., a biotechnology company, engages in the discovery, development, and commercialization of autologous cellular therapies for the treatment of chronic and acute heart damage, and vascular and autoimmune diseases in the United States. The company’s lead product candidates include MyoCell, a clinical therapy designed to populate regions of scar tissue within a patient’s heart with autologous muscle cells or cells from a patient’s body for enhancing cardiac function in chronic heart failure patients; and AdipoCell, a patient-derived cell therapy for the treatment of acute myocardial infarction, chronic heart ischemia, and lower limb ischemia. Its pipeline products include MyoCell SDF-1, an autologous muscle-derived cellular therapy for enhancing cardiac function in chronic heart failure patients. The company is also developing MyoCath, a deflecting tip needle injection catheter that is used to inject cells into cardiac tissue in therapeutic procedures to treat chronic heart ischemia and congestive heart failure. In addition, it provides physician and patient based regenerative medicine/cell therapy training, cell collection, and cell storage services; and cell collection and treatment kits for humans and animals, as well as operates a cell therapy clinic to provide cellular treatments for patients afflicted with neurological, autoimmune, orthopedic, and degenerative diseases. The company also offers various courses for physicians and other health care professionals. The company was formerly known as Bioheart, Inc. and changed its name to U.S. Stem Cell, Inc. in October 2015. U.S. Stem Cell, Inc. was incorporated in 1999 and is headquartered in Sunrise, Florida.

Contact Information

Address 1560 Sawgrass Corporate Parkway 4th Floor
Sunrise, 33323
United States
Phone 954 835 1500
Fax 954 845 9976

Top Executives

Name Age Since Title
Gregory Knutson 69 2017 Director
Edward M. Diethrich 86 - Member of Scientific Advisory Board
James R. Margolis - - Member of Scientific Advisory Board
Doris A. Taylor - 1999 Member of Scientific Advisory Board
Jorge Genovese - 2007 Member of Scientific Advisory Board
Stephen Ramee - - Member of Scientific Advisory Board
Eric Crumpler - - Member of Scientific Advisory Board
Syde A. Taheri - - Member of Scientific Advisory Board
Marc Steven Penn - - Member of Scientific Advisory Board
Race L. Kao - - Member of Scientific Advisory Board
Felipe Prósper - - Member of Scientific Advisory Board
Richard R. Heuser - - Member of Scientific Advisory Board
George J. Magovern - - Member of Scientific Advisory Board
Nicolas A. F. Chronos 60 - Member of Scientific Advisory Board
Stuart K. Williams - - Member of Scientific Advisory Board
Harold Ott - - Member of Scientific Advisory Board
Stephen G. Ellis - - Member of Scientific Advisory Board
Robert S. Schwartz - - Member of Scientific Advisory Board
Warren Sherman 70 - Member of Scientific Advisory Board
Camillo Ricordi 64 - Member of Scientific Advisory Board
Christopher M. O’Connor - - Member of Scientific Advisory Board
Nicholas S. Peters - - Member of Scientific Advisory Board
Michael Tomas 55 2010 CEO, President, CFO & Director
Keith L. March - - Member of Scientific Advisory Board
Wendell King - - Member of Scientific Advisory Board
Barry T. Katzen 74 - Member of Scientific Advisory Board
Juan C. Chachques - - Member of Scientific Advisory Board
Miranda Grounds - - Member of Scientific Advisory Board
Sheldon T. Anderson 70 2013 Director
Ray Chiu - - Member of Scientific Advisory Board
Robert A. Van Tassel 80 - Member of Scientific Advisory Board
Sergio Pinski - 2004 Medical Director & Member of Scientific Advisory Board
Mark P. Borman 67 2009 Chairman
William P. Murphy 98 2003 Chairman Emeritus
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

USRM Comments

Write your thoughts about US Stem Cell Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email